Drug-induced hypersensitivity syndrome like reaction with angioedema and hypotension associated with BRAF inhibitor use and antecedent immune checkpoint therapy

• Jasmine Rana, MD,
• Nolan J. Maloney, MD,
• Kerri E. Rieger, MD, PhD,
• Silvina B. Pugliese, MD,
• Jenna L. Strelo, MSN, RN,
• Anne Liu, MD,
• Lisa C. Zaba, MD, PhD,
• Bernice Y. Kwong, MD

Affiliations

Jasmine Rana, MD

Department of Dermatology, Stanford University Medical Center and Cancer Institute, Palo Alto, California

Nolan J. Maloney, MD

Division of Dermatology, Department of Medicine, David Geffen School of Medicine, The University of California, Los Angeles, California

Kerri E. Rieger, MD, PhD

Department of Dermatology, Stanford University Medical Center and Cancer Institute, Palo Alto, California

Silvina B. Pugliese, MD

Department of Dermatology, Stanford University Medical Center and Cancer Institute, Palo Alto, California

Jenna L. Strelo, MSN, RN

Department of Dermatology, Stanford University Medical Center and Cancer Institute, Palo Alto, California

Anne Liu, MD

Department of Dermatology, Stanford University Medical Center and Cancer Institute, Palo Alto, California

Lisa C. Zaba, MD, PhD

Department of Dermatology, Stanford University Medical Center and Cancer Institute, Palo Alto, California

Bernice Y. Kwong, MD

Department of Dermatology, Stanford University Medical Center and Cancer Institute, Palo Alto, California; Correspondence to: Dr Bernice Y. Kwong, Department of Dermatology, Stanford University Medical Center and Cancer Institute, 780 Welch Road, CJ220F, Palo Alto, CA 94304-5779.